Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

Clinical trial NCT05275439 · TERMINATED

Trial details

NCT number: NCT05275439
Sponsor: Shattuck Labs, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes

Start date: 2022-03-17
Primary completion: 2025-02-06
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.